Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty
Atsunori Okamura, Tomohiro Katsuya(Japan Medical Association), Hiromi Rakugi(Osaka Rosai Hospital), Hiroshi Ito(University of Tsukuba Hospital), Shin Takiuchi(Sakurabashi Watanabe Hospital), Yoshihiro Yanagitani(The University of Osaka), Yoshiaki Taniyama(The University of Osaka), Koichi Moriguchi(Osaka University), Kenshi Fujii(Sakurabashi Watanabe Hospital), Mitsuru Ohishi(Kagoshima University), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Yorihiko Higashino(Sakurabashi Watanabe Hospital), Toshio Ogihara(Osaka University)
Cited by 38
Related Papers
Diagnostic Performance of Noninvasive Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography in Suspected Coronary Artery Disease
|Journal of the American College of Cardiology|2014|1.5k
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821